brand logo

Am Fam Physician. 2004;70(12):2358-2359

Clinical Question: Is a dosage of 40 mg of omeprazole per day more effective than a dosage of 20 mg per day for primary care patients with dyspepsia?

Setting: Outpatient (primary care)

Study Design: Randomized controlled trial (double-blinded)

Allocation: Concealed

Synopsis: A common strategy in primary care for patients with dyspepsia and no alarm symptoms is to prescribe a proton pump inhibitor. This pragmatic study took place in a Danish primary care research network with 103 participating physicians and 829 patients. Adults presenting with dyspepsia (thought to be acid-related) and no alarm symptoms were randomized to treatment with omeprazole in a dosage of 40 mg per day, omeprazole in a dosage of 20 mg per day, or placebo. Alarm symptoms were defined as rectal bleeding or hematemesis, unintended weight loss, vomiting, dysphagia, jaundice, or other signs of serious disease. Groups were similar at baseline, with a mean age of 50 years; 58 percent were women. Allocation was concealed and outcomes were assessed blindly, with analysis by intention to treat.

Patients were treated for two weeks, and then medications were discontinued. During the remaining year of observation, in which 92 percent of patients participated, the author tracked the time until symptom relapse and the use of health care resources. The most common symptoms in both groups were epigastric pain, regurgitation, heartburn, bloating, and pain at night. Symptoms were rated as moderate by 63 percent of patients and severe by 15 percent.

At two weeks, sufficient relief was reported more often by subjects in the 40-mg and 20-mg omeprazole groups than in the placebo group (71.0, 69.6, and 43.0 percent, respectively), as was complete relief (66.4, 63.0, and 34.9 percent, respectively). The number needed to treat was between three and four for both outcomes. Results were similar for Helicobacter pylori-positive and H. pylori-negative patients. Most patients in all three groups had a symptom relapse during the year following their initial treatment.

Bottom Line: Omeprazole in a dosage of 20 mg per day is highly effective for the treatment of acid-related dyspepsia. There is no advantage to higher dosages, and relapse following the initial two-week treatment period is common. (Level of Evidence: 1b)

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to

This series is coordinated by Natasha J. Pyzocha, DO, contributing editor.

A collection of POEMs published in AFP is available at

Continue Reading

More in AFP

Copyright © 2004 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.